← Leaderboards
Alexander Paul Glaser
Northwestern University At Chicago
$1,854,491
Attributed
$4,613,882
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$4,613,882 · 2
By mechanism
R01$4,613,882 · 2
Top collaborators
- James William Griffith5 shared
- Abigail Smith5 shared
- Simon W. Hayward3 shared
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Praveen Thumbikat$10,960,544
- Zachary Smith$2,836,975
- Abigail Smith$2,712,071
- James William Griffith$7,291,641
- Yuan Luo$4,961,840
Others in their field
Other Rising Stars on “Diagnosis”
- David Annett · Information Management Services, Inc.$35,571,865
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Jennifer Lee O'Brien · University Of South Florida$15,110,862
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- John Alam · Eip Pharma, Inc.$10,411,018
Research focus
DiagnosisComorbidityProstateProstaticIntravesicalBenign Prostatic HypertrophyLower Urinary Tract SymptomsPatient Outcomes AssessmentsSeveritiesSymptomsOperative Surgical ProceduresMedicalDistressEffective TherapyAssociated SymptomAftercareClinical Decision-MakingEvidence Based TreatmentAnxietyDesignComplexCounselingClinicCaring
Grant awards (8)
Effects of TNF Blockade on Human BPH/LUTS$711,954
R01 · FY2025 · DK
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes$600,253
R01 · FY2025 · DK
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes$629,661
R01 · FY2024 · DK
Effects of TNF Blockade on Human BPH/LUTS$596,241
R01 · FY2024 · DK
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes$669,698
R01 · FY2023 · DK
Effects of TNF Blockade on Human BPH/LUTS$590,984
R01 · FY2023 · DK
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes$99,997
R01 · FY2023 · DK
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes$715,094
R01 · FY2022 · DK